← Back to Search

Other

Avocado for Type 2 Diabetes (AVOCADO-T2D Trial)

N/A
Recruiting
Led By John W Apolzan, PhD
Research Sponsored by Pennington Biomedical Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant reported diagnosis of Type 2 diabetes
Age range - 18 - 65 years (inclusive)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 5 - week 0
Awards & highlights

AVOCADO-T2D Trial Summary

This trial will study how eating avocados affects blood sugar levels compared to other fruits.

Who is the study for?
This trial is for adults aged 18-65 with Type 2 diabetes, a BMI of 27-50, and stable blood sugar control medication. Participants must not be pregnant or trying to conceive, have recent major surgery, unstable heart disease, severe kidney issues, or be on weight loss drugs. They should agree to consume avocados and follow the study protocol.Check my eligibility
What is being tested?
The study aims to see if eating Hass Avocados can improve blood sugar levels in people with Type 2 diabetes compared to consuming an equal calorie amount of other fruits during controlled feeding conditions.See study design
What are the potential side effects?
While avocados are generally safe and nutritious, some individuals might experience mild digestive discomfort or allergic reactions when consuming them as part of their diet.

AVOCADO-T2D Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Type 2 diabetes.
Select...
I am between 18 and 65 years old.

AVOCADO-T2D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 5 - week 0
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 5 - week 0 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fasting Blood Glucose
Secondary outcome measures
Fasting Insulin
Fructosamine
Glycated Albumin
Other outcome measures
Blood Glucose
Glucose
Insulin

AVOCADO-T2D Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: AvocadoExperimental Treatment1 Intervention
Participants will consume 1 Hass avocado a day.
Group II: Other Fruit(s)Active Control1 Intervention
Participants in the other fruit arm will receive other fruits.

Find a Location

Who is running the clinical trial?

Pennington Biomedical Research CenterLead Sponsor
305 Previous Clinical Trials
181,988 Total Patients Enrolled
Prachi SinghUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
Frank L. GreenwayUNKNOWN
3 Previous Clinical Trials
67 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age range for participants in this trial inclusive of those over 30?

"As per the requirements of this trial, participants must be 18 years old or above and younger than 65."

Answered by AI

Could you provide an estimate of the overall participation rate in this trial?

"Affirmative. According to clinicaltrials.gov, this therapeutic study is presently recruiting potential participants and was initially published on October 10th 2023 with a recent update made on the 24th of October. The research team are looking for 48 patients from one medical centre."

Answered by AI

Is the research team actively recruiting new participants for this investigation?

"Affirmative. According to the information on clinicaltrials.gov, this clinical trial has been actively recruiting since it was first posted on October 10th 2023 and most recently updated on October 24th 2023. The study requires 48 participants from one location for participation."

Answered by AI

Can I be part of this research experiment?

"This clinical trial is searching to enrol 48 individuals, whose ages are between 18 and 65 years old, who have been diagnosed with type 2 diabetes. In addition, the following criteria must be met: Participant-reported diagnosis of Type 2 diabetes; Hemoglobin A1c (HbA1c) levels that range from 5.7 - 11% (inclusive); Fasting blood glucose level of at least 100 milligrams per deciliter; Body Mass Index (BMI) ranging 27 - 50 kilograms per meter squared; Stable regimen for all medications administered over a period of 3 months or more prior to enrollment; Willing"

Answered by AI
~32 spots leftby Jun 2025